Evaluating the Impact of Absolute Lymphocyte Count on Outcomes in ATG Containing Haploidentical HSCT for Acute Myeloid Leukemia

被引：0
|
作者：
Kwag, Daehun [1 ,2 ]
Lee, Jung Yeon [1 ,2 ]
Min, Gi June [1 ,2 ]
Park, Sung-Soo [1 ,2 ]
Park, Silvia [1 ,2 ]
Yoon, Jae-Ho [1 ,2 ]
Lee, Sung-Eun [1 ,2 ]
Eom, Ki-Seong [1 ,2 ]
Kim, Yoo-Jin [1 ,2 ]
Lee, Seok [1 ,2 ]
Kim, Hee-Je [1 ,2 ]
Min, Chang-Ki [1 ,2 ]
Cho, Seok-Goo [2 ]
Cho, Byoung-Sik [1 ,2 ]
机构：
[1] Catholic Univ Korea, Leukemia Res Inst, Coll Med, Seoul, South Korea
[2] Catholic Univ Korea, Seoul St Marys Hematol Hosp, Coll Med, Dept Hematol, Seoul, South Korea
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-212406
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7327 / 7328
页数：2
相关论文
共 50 条
  • [41] Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia
    Behl, D
    Porrata, LF
    Markovic, SN
    Letendre, L
    Pruthi, RK
    Hook, CC
    Tefferi, A
    Elliot, MA
    Kaufmann, SH
    Mesa, RA
    Litzow, MR
    LEUKEMIA, 2006, 20 (01) : 29 - 34
  • [42] Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia
    D Behl
    L F Porrata
    S N Markovic
    L Letendre
    R K Pruthi
    C C Hook
    A Tefferi
    M A Elliot
    S H Kaufmann
    R A Mesa
    M R Litzow
    Leukemia, 2006, 20 : 29 - 34
  • [43] COMPARISONS OF ATG-THYMOGLOBULIN (ATG-T) WITH ATG-FRESENIUS (ATG-F) TO OPTIMIZE CONDITIONING REGIMENS FOR HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Cao, Xing-Yu
    Liu, De-Yan
    Zhang, Jian-Ping
    Xiong, Min
    Wei, Zhi-Jie
    Zhou, Jia-Rui
    Lu, Yue
    Sun, Rui-Juan
    Zhao, Yan-Li
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 258 - 258
  • [44] REDEFINE CLINICAL RISK CLASSIFICATION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA USING INITIAL ABSOLUTE LYMPHOCYTE COUNT
    Suppipat, K.
    Fungpipat, P.
    Sophonpan, J.
    Sosothikul, D.
    HAEMATOLOGICA, 2015, 100 : 33 - 34
  • [45] Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia
    Olson, Amanda L.
    Saliba, Rima M.
    Oran, Betul
    Chen, Julianne
    Alousi, Amin
    Ahmed, Sairah
    Bashir, Qaiser
    Ciurea, Stefan O.
    Hosing, Chitra
    Seon Im, Jin
    Kebriaei, Partow
    Khouri, Issa F.
    Mehta, Rohtesh
    Nieto, Yago
    Parmar, Simrit
    Rezvani, Katy
    Shah, Nina
    Shpall, Elizabeth
    Srour, Samer A.
    Qazilbash, Muzaffar
    Andersson, Borje S.
    Champlin, Richard
    Popat, Uday R.
    ACTA HAEMATOLOGICA, 2021, 144 (01) : 74 - 81
  • [46] Initial absolute monocyte count as an immune biomarker for clinical response in acute myeloid leukemia with monocytic differentiation
    Embaby, Ahmed
    Fathy, Ayman
    Al-Akkad, Mohammad
    Baraka, Ahmad
    Ibrahim, Taiseer
    Zidan, Nahla
    Refaat, Mohamed
    Elsheikh, Haitham
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2020, 32 (01)
  • [47] Initial absolute monocyte count as an immune biomarker for clinical response in acute myeloid leukemia with monocytic differentiation
    Ahmed Embaby
    Ayman Fathy
    Mohammad Al-Akkad
    Ahmad Baraka
    Taiseer Ibrahim
    Nahla Zidan
    Mohamed Refaat
    Haitham Elsheikh
    Journal of the Egyptian National Cancer Institute, 32
  • [48] Early Absolute Lymphocyte Count Is a Strong Predictor of Long Term Improved Survival in Childhood Acute Myeloid Leukaemia
    Keenan, Russell
    Williamson, Rebecca
    Caswell, Mark
    Salim, Rahuman
    Campbell, Helen Jane
    BLOOD, 2012, 120 (21)
  • [49] Idarubicin-intensified haploidentical HSCT with GvHD prophylaxis of ATG and basiliximab provides comparable results to sibling donors in high-risk acute leukemia
    R Zhang
    W Shi
    H-F Wang
    Y You
    Z-D Zhong
    W-M Li
    C Zhang
    X Lu
    Y-D Wang
    P Zheng
    J Fang
    M Hong
    Q-L Wu
    L-H Xia
    Bone Marrow Transplantation, 2017, 52 : 1253 - 1260
  • [50] Idarubicin-intensified haploidentical HSCT with GvHD prophylaxis of ATG and basiliximab provides comparable results to sibling donors in high-risk acute leukemia
    Zhang, R.
    Shi, W.
    Wang, H-F
    You, Y.
    Zhong, Z-D
    Li, W-M
    Zhang, C.
    Lu, X.
    Wang, Y-D
    Zheng, P.
    Fang, J.
    Hong, M.
    Wu, Q-L
    Xia, L-H
    BONE MARROW TRANSPLANTATION, 2017, 52 (09) : 1253 - 1260
12345